Figure 11.
(A) General structure of compounds 8.86–8.147. (B) Design principle and key compounds in the programme with some of their pharmacological properties. In red and blue marked are fragments subject to hybridization.
(A) General structure of compounds 8.86–8.147. (B) Design principle and key compounds in the programme with some of their pharmacological properties. In red and blue marked are fragments subject to hybridization.